Gallen consensus, breast cancer can be divided into luminal and non-luminal subtypes based on the expression levels of hormone receptors, which are estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2) (3). Here, ERBB2 is linked to breast carcinoma.